Metabolon’s first offering from its SmartPanel portfolio aims to provide drug discovery and precision medicine researchers with a novel, dynamic process to explore biologically relevant views of metabolomic data in the context of specific metabolic pathways, biological themes, and disease associations. “The metabolome offers a window into human… Read More
THREAD has acquired Modus Outcomes to combine high-technology and high-science in one platform designed to achieve higher-quality outcomes for research sponsors. As clinical trials have grown more complex, so has effectively designing and implementing endpoints, which are now required in most research studies. With this acquisition, THREAD… Read More
X-Chem has announced the acquisition of Glamorous AI, combining X-Chem’s DNA-encoded library (DEL) data with the AI capabilities of Glamorous AI. This reportedly positions X-Chem as a leading service provider in machine learning-driven drug discovery. “What AlphaFold did for protein folding, X-Chem and Glamorous AI will do for drug… Read More
Emmes has launched a rare disease centre, Orphan Reach, to combine its health research across the public sector and biopharmaceutical industry, with Orphan Reach, a UK-based CRO, acquired by Emmes in May 2021. The expanded Orphan Reach is dedicated to the advancement of rare disease research by providing specialised clinical… Read More
PreOmics, developer of tools for mass spectrometry-based protein analyses, has launched BeatBox, its new sample preparation tool for tissues and cells. BeatBox delivers tissue homogenisation and can process up to 96 tissue samples in 10 minutes from 1-5 mg of tissue, with no cross-contamination. According to… Read More
TARA Biosystems, a biotechnology company using human biology and data for cardiac drug discovery, has collaborated with Scipher Medicine, a precision medicine company. The collaboration will address a critical unmet need for effective therapeutics in cardiac laminopathies. Cardiac laminopathies, associated with mutations in the LMNA gene, can result in… Read More
Nautilus Biotechnology and Abcam have announced a strategic development and supply partnership to leverage Abcam’s recombinant monoclonal antibody development technologies and expertise to enhance Nautilus’ reagent research and development. The partnership will initially focus on the collaborative development of affinity binding reagents for use on the… Read More
Drug discovery contract research organizations (CROs) offer an established infrastructure and experience that offers promising paths forward for various research projects. However, partnering with a CRO also presents key challenges, and companies should consider three questions: How long until data is delivered? Will the quality of the data instill confidence… Read More
Inscopix, a brain mapping platform, appointed David Gray as Chief Scientific Officer (CSO) in a new position to discover and develop more effective therapies for brain disorders. Inscopix provides brain research tools to basic and translational researchers in academia as well as biotech and pharma companies in neuroscience. Read More
Sartorius was named the award winner for “Overall Best Bioprocessing Supplier” at the Europe Bioprocessing Excellence Awards 2021. According to award organizer IMAPAC, the awards seek to recognise exceptional bioprocessing experts, organisations, and technologies that facilitate biomanufacturing excellence at enhanced speed, reduced cost, and superior quality across Europe and the… Read More
Drug discovery contract research organizations (CROs) offer an established infrastructure and experience that offers promising paths forward for various research projects. However, partnering with a CRO also presents key challenges, and companies should consider three questions: How long until data is delivered? Will the quality of the data instill confidence… Read More
New research, involving 200 professionals in senior roles spanning pharmacovigilance (PV), Drug Safety and Product Safety departments, has found that quality has overtaken cost as a priority in plans for automating adverse event (AE) reporting. John Price, life sciences industry consultant and partner of Arriello, which commissioned this latest research, reports on the findings. Although the Covid-19 pandemic has… Read More
The Cell & Gene Collective publicly launched in May 2021. Lu Rahman caught up with Julian Cole, Country Medical Director of Gilead Sciences for the UK and Ireland to find out more about this cross-industry alliance between Astellas, bluebird bio, Bristol Myers Squibb, Kite (a Gilead company) and Novartis. LR: What was… Read More
Advances in treatments for human diseases, including cancer, rely on the ability to gain detailed information into the function, modulation, and variation of the immune system in response to stimuli or immunological challenge. Insights derived from these data have, for example, revolutionized cancer treatment by enabling the development of adoptive… Read More
Beckley Psytech, a clinical stage, biotechnology company dedicated to addressing neuropsychiatric disorders through the novel application of psychedelic medicines, has appointed Frank Wiegand as Chief Medical Officer. Dr. Wiegand, a trained neurologist and neuroscientist, joins Beckley Psytech after more than 20 years with Janssen (a Johnson & Johnson company), where… Read More
BioNet and BIA Separations, now part of Sartorius, have developed an optimised mRNA manufacturing process. BIA’s expertise in chromatographic columns for mRNA purification combined with BioNet’s expertise in the product development of genetic vaccines have, since early 2021, enabled both teams to collaborate on the optimisation and upscale of a high-yield… Read More
